Literature DB >> 34122540

Corrigendum to "Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori".

Lingyun Zhang1, Yu Lan1, Qi Wang1, Yuexia Zhang1, Xiaobei Si1.   

Abstract

[This corrects the article DOI: 10.1155/2019/9251879.].
Copyright © 2021 Lingyun Zhang et al.

Entities:  

Year:  2021        PMID： 34122540      PMCID： PMC8169254          DOI： 10.1155/2021/9823426

Source DB:  PubMed          Journal:  Gastroenterol Res Pract        ISSN： 1687-6121            Impact factor:   2.260


In the article titled “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori” [1], there was an error in Subjects and Methods. This error is shown below: “(Wyeth-Palace Pharmaceutical Co., Ltd, 1.0g, BID)” should read “(Wyeth-Palace Pharmaceutical Co., Ltd, 0.1 g, BID).”
  1 in total

1.  Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori.

Authors:  Lingyun Zhang; Yu Lan; Qi Wang; Yuexia Zhang; Xiaobei Si
Journal:  Gastroenterol Res Pract       Date:  2019-12-18       Impact factor: 2.260
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.